Geneos Wealth Management Inc. Raises Position in British American Tobacco p.l.c. $BTI

Geneos Wealth Management Inc. grew its holdings in shares of British American Tobacco p.l.c. (NYSE:BTI) by 40.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,618 shares of the company’s stock after purchasing an additional 1,048 shares during the quarter. Geneos Wealth Management Inc.’s holdings in British American Tobacco were worth $150,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in BTI. Rosenberg Matthew Hamilton raised its position in shares of British American Tobacco by 87.0% in the 1st quarter. Rosenberg Matthew Hamilton now owns 602 shares of the company’s stock worth $25,000 after buying an additional 280 shares during the period. Golden State Wealth Management LLC raised its position in shares of British American Tobacco by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 610 shares of the company’s stock worth $25,000 after buying an additional 305 shares during the period. Ameriflex Group Inc. purchased a new position in shares of British American Tobacco in the 4th quarter worth $26,000. Financial Management Professionals Inc. raised its position in shares of British American Tobacco by 78.5% in the 1st quarter. Financial Management Professionals Inc. now owns 632 shares of the company’s stock worth $26,000 after buying an additional 278 shares during the period. Finally, Mather Group LLC. raised its position in shares of British American Tobacco by 292.7% in the 1st quarter. Mather Group LLC. now owns 644 shares of the company’s stock worth $27,000 after buying an additional 480 shares during the period. 16.16% of the stock is owned by hedge funds and other institutional investors.

British American Tobacco Stock Down 0.4%

Shares of British American Tobacco stock opened at $55.80 on Wednesday. The business has a 50-day moving average of $55.13 and a 200-day moving average of $47.66. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.87 and a quick ratio of 0.55. The company has a market capitalization of $114.81 billion, a PE ratio of 11.46, a P/E/G ratio of 3.85 and a beta of 0.40. British American Tobacco p.l.c. has a 1-year low of $34.17 and a 1-year high of $59.29.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on BTI shares. Wall Street Zen lowered British American Tobacco from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Argus raised British American Tobacco from a “hold” rating to a “buy” rating and set a $62.00 price objective on the stock in a research report on Monday, September 8th. Royal Bank Of Canada lowered British American Tobacco from a “sector perform” rating to an “underperform” rating in a research report on Tuesday, September 2nd. Barclays reissued an “overweight” rating on shares of British American Tobacco in a research report on Friday, June 13th. Finally, Jefferies Financial Group began coverage on British American Tobacco in a research report on Wednesday, July 9th. They issued a “buy” rating on the stock. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, British American Tobacco currently has a consensus rating of “Hold” and an average target price of $51.00.

British American Tobacco Company Profile

British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands.